Membrane complement regulatory proteins: Insight from animal studies and relevance to human diseases

International Immunopharmacology

Volumn 1, Issue 3, 2001, Pages 445-459

  Miwa, Takashi ^a   Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherosclerosis; Autoimmune disease; CD59; Complement; Complement regulatory proteins; Crry; DAF (CD55); Fetomaternal tolerance; Knockout mouse; MCP (CD46); PNH; Reproduction; Sperm; Transgenic mouse

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; PROTEIN CRRY; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFERENCE PAPER; CONSENSUS SEQUENCE; FERTILITY; GUINEA PIG; HOST CELL; HOST RESISTANCE; HUMAN; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SWINE; TISSUE DISTRIBUTION; TISSUE INJURY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; ANTIGENS, SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; GUINEA PIGS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MODELS, ANIMAL; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; SWINE;

EID: 0035094143     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(00)00043-6     Document Type: Conference Paper

References (140)

1. Physiology and pathophysiology of complement: Progress and trends
2. The lectin pathway of the complement system
3. Biochemistry and biology of anaphylatoxin
4. Structure, function and cellular expression of complement anaphylatoxin receptors
5. The regulators of complement activation (RCA) gene cluster
6. Decay-accelerating factor: Biochemistry, molecular biology, and function
7. Membrane cofactor protein (MCP or CD46): Newest member of the regulators of the complement activation gene cluster
8. Structure and function of the complement receptors, CR-1 (CD35) and CR-2 (CD21)
9. CD59, an Ly-6-like protein expressed in human lymphoid-cells, regulates the action of the complement membrane attack complex on homologous cells
10. Human protectin (CD59), an 18,000-20,000 MW complement lysis restriction factor, inhibits C5b-8 catalyzed insertion of C9 into lipid bilayers
11. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
12. Paroxysmal nocturnal haemoglobinuria
13. Cloning of decay-accelerating factor suggests a novel use of splicing to generate two proteins
14. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
15. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses
16. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method
17. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)
18. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase
19. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical C3 convertase, C4b,2a
20. Isolation of decay-accelerating factor (DAF) from rabbit erythrocyte membranes
21. A monoclonal antibody which blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor
22. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing
23. Molecular cloning of murine decay-accelerating factor by immunoscreening
24. Mouse decay-accelerating factor: Selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form
25. Molecular cloning and chromosomal localization of the mouse decay accelerating factor genes
26. Molecular and functional analysis of mouse decay accelerating factor (CD55)
27. Alternative exon usage in the 3′ region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor
28. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats
29. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)
30. Molecular cloning and functional characterization of the pig analogue of CD59: Relevance to xenotransplantation
31. Tissue distribution of the guinea-pig decay-accelerating factor
32. Tissue distribution of the rat analogue of decay-accelerating factor
33. Characterization of mouse DAF on transfected cells using monoclonal antibodies which recognize different epitopes
34. Functional differences among multiple isoforms of guinea pig decay-accelerating factor
35. Cloning and characterization of murine decay accelerating factor
36. A direct comparison of complement inhibitory capacities of the GPI- and transmembrane forms of mouse DAF to mouse Crry and human rsCR1
37. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
38. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF
39. Molecular cloning and characterization of mouse CD97
40. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)
41. Membrane cofactor protein of the complement system: Alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype
42. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing
43. Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing
44. Identification and characterization of membrane cofactor protein of human spermatozoa
45. Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjects
46. Inhibition of human sermatozoa-oocyte interaction in vitro by monoclonal antibodies to CD46 (membrane cofactor protein)
47. The role of complement component C3b and its receptors in sperm-oocyte interaction
48. Localization and characterization of the acrosomal antigen recognized by GB24 on human spermatozoa
49. The complement system in human reproduction
50. The human CD46 molecule is a receptor for measles virus (Edmonston strain)
51. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus
52. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
53. Mapping of the primary binding site of measles virus to its receptor CD46
54. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding
55. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein
56. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46
57. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46)
58. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2
59. Molecular cloning of guinea pig membrane cofactor protein
60. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)
61. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): Preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1
62. Molecular cloning of a pig homologue of membrane cofactor protein (CD46)
63. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): Preferential expression in testicular germ cells
64. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP)
65. Membrane and secretory forms of mouse membrane cofactor protein (CD46) generated from a single gene through alternative splicing
66. Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes
67. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1
68. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP
69. Genetic organization of complement receptor-related genes in the mouse
70. Identification of murine complement receptor type 2
71. The murine complement receptor gene family: IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1
72. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2
73. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative
74. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
75. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
76. Immunomodulatory functions of murine CR1/2
77. The evolution of mouse and human complement C3-binding proteins: Divergence of form but conservation of function
78. Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF
79. The murine complement receptor gene family: III. The genomic and transcriptional complexity of the Crry and Crry-ps genes
80. Molecular characterization of rat Crry: Widespread distribution of two alternative forms of Crry mRNA
81. Molecular cloning of the rat complement regulatory protein, 5I2 antigen
82. Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family
83. Characterization of a murine cDNA with both intra- and extracytoplasmic homology to human CR1
84. Complement inhibitor of rat cell membrane resembling mouse Crry/p65
85. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins
86. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1
87. Mouse complement regulatory protein Crry/p65 uses the specific mechanism of both human decay-accelerating factor and membrane cofactor protein
88. Tissue distribution of complement regulatory membrane proteins in rats
89. Role of decayaccelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
90. A critical role for murine complement regulator Crry in fetomaternal tolerance
91. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
92. Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement
93. The sheep analogue of human CD59: Purification and characterization of its complement inhibitory activity
94. Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies
95. A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: Application to pig CD59
96. Molecular cloning of the rat analogue of human CD59: Structural comparison with human CD59 and identification of a putative active site
97. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59
98. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59
99. Colocalization of the human CD59 gene to 11p13 with the MIC11 cell surface antigen
100. Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter
101. Structure of the CD59-encoding gene-further evidence of a relationship to murine lymphocyte antigen LY-6 protein
102. Gene structure of human CD59 and demonstration that discrete messenger-RNAs are generated by alternative polyadenylation
103. Genomic structure and chromosome location of the gene encoding mouse CD59
104. Expression of rat CD59: Functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function
105. Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted
106. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9
107. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection
108. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats
109. Role of CD59 in experimental glomerulonephritis in rats
110. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement
111. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
112. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor
113. Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury
114. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
115. Production and functional characterization of a soluble recombinant form of mouse CD59
116. Knocking out mouse CD59 using a PCR derived gene targeting vector
117. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
118. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities
119. Pathogenesis of glomerular damage in glomerulonephritis
120. The role of the complement system in renal injury
121. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
122. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice
123. Complement and atherogenesis: The unknown connection (Editorial)
124. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits
125. Molecular basis for a link between complement and the vascular complications of diabetes
126. Epidemiology of cardiovascular disease in systemic lupus erythematosus
127. Recent insights into antiphospholipid antibody-mediated thrombosis
128. Decay-accelerating factor functions as a signal transducing molecule for human T cells
129. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells
130. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases
131. A monoclonal antibody to the rat Crry/p65 antigen, a complement regulatory membrane protein, stimulates adhesion and proliferation of thymocytes
132. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells
133. Membrane cofactor protein (MCP; CD46): Isoform-specific tyrosine phosphorylation
134. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation
135. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretin receptor superfamily with an unusual extracellular domain
136. Decay-accelerating factor in guinea pig stomachs following ischemia reperfusion stress
137. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition
138. Deficiency of decay-accelerating factor (DAF) attenuates leukocyte-endothelium interaction induced by hemorrhage and reinfusion